6W3-31301-26321
2 vaccinations
9 coded responses
23 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-08-26
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-26
Registered in v-safe
-
2021-08-26
Dose 1 — Pfizer-BioNTech
- 2021-08-26
-
2021-08-27
Survey response — days 1–6 daily, dose 1MedDRA: Head discomfort — Feeling: Fair · Site: Pain · FeverFree text: Head heavyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-29
Survey response — days 1–6 daily, dose 1MedDRA: Hunger — Feeling: Fair · Fatigue or tiredness, NauseaFree text: Hungry all the timeMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-30
- 2021-08-31
-
2021-09-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
-
2021-09-02
Health check-in — day 7, dose 1Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-09-09
-
2021-09-16
Dose 2 — Pfizer-BioNTech
-
2021-09-16
Survey response — day 0, dose 2MedDRA: Heart rate increased, Nasopharyngitis, Tremor — Feeling: Poor · Fatigue or tiredness · Be unable to work or attend schoolFree text: Rapid heart rate 175, cold, shakingMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased, Unevaluable event — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Heart rate 130 · Healthcare visit (other): EKGMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-18
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend schoolFree text: Heart rate 130MedDRA releases: 2024-11 · check-in free text available
-
2021-09-19
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Fair · Fatigue or tiredness, VomitingFree text: Higher heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-09-20
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-09-22
- 2021-09-23
-
2021-10-01
Survey response — day 14, dose 2MedDRA: Insomnia — Feeling: FairFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
-
2021-10-14
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-10-21
-
2021-10-30
Survey response — day 42, dose 2MedDRA: Asthenia, Headache, Heart rate increased, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Running, stuffy nose, Sore throat, headache, weak and high heart rate(130 while standing)MedDRA releases: 2024-11 · check-in free text available
- 2021-12-18
- 2022-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-26 | Pfizer-BioNTech | No |
| 2 | 2021-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-17 | Successful 2021-09-20 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Head heavy
Systemic reaction (other): Hungry all the time
Release 9 — day 0, dose 2
Systemic reaction (other): Rapid heart rate 175, cold, shaking
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Heart rate 130
Systemic reaction (other): Higher heart rate
Release 9 — day 14, dose 2
Symptoms: Insomnia
Release 10 — day 28, dose 2
Symptoms: Fatigue
Release 10 — day 42, dose 2
Symptoms: Running, stuffy nose, Sore throat, headache, weak and high heart rate(130 while standing)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Head discomfort | ✓ | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Hunger | ✓ | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Tremor | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release